Omeprazole immediate release formulation
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole Immediate Release Formulation: Key Features and Mechanisms
Immediate-release (IR) omeprazole formulations are designed to address the limitations of traditional delayed-release (DR) omeprazole, which requires enteric coating to protect the drug from stomach acid and results in delayed absorption and onset of action Peura2005Peura2005Castell2005. The IR formulations use buffering agents, most commonly sodium bicarbonate, to protect omeprazole from acid degradation, allowing for rapid drug release and absorption in the stomach Peura2005Castell2005Ramesh2025.
Formulation Strategies: Buffering Agents and Microencapsulation
The most common approach in IR omeprazole formulations is the inclusion of sodium bicarbonate, which neutralizes gastric acid and stabilizes omeprazole, enabling immediate release and absorption Peura2005Castell2005Ramesh2025+2 MORE. Some formulations also use magnesium hydroxide or magnesium oxide as additional antacids to further increase gastric pH and protect the drug Qi-Neng2007Ramesh2025. Microencapsulation with hydroxypropyl cellulose (HPC) has also been used to delay dissolution slightly, but the main protective effect comes from the antacid agents .
Pharmacokinetics and Rapid Onset of Action
IR omeprazole formulations achieve faster absorption and higher peak plasma concentrations (Cmax) compared to DR formulations, with maximum concentrations reached within 30 minutes in some studies Liu2013Ramesh2025. The time to reach peak concentration (Tmax) is shorter, and the onset of acid suppression is quicker, making these formulations suitable for on-demand therapy and for patients who may not comply with mealtime dosing Peura2005Castell2005Liu2013. The overall extent of absorption (AUC) is similar to DR formulations, but the rate is significantly increased .
Clinical Benefits: Nocturnal Acid Control and Flexible Dosing
IR omeprazole provides more rapid and sustained elevation of gastric pH, especially when administered at bedtime, offering better control of nocturnal gastric acidity than conventional morning dosing of DR PPIs Castell2005Peura2005Peura2005. This makes IR omeprazole particularly useful for patients with nocturnal reflux symptoms or those needing flexible, on-demand dosing Peura2005Castell2005. It is also approved for reducing the risk of upper gastrointestinal bleeding in critically ill patients, where rapid and reliable acid suppression is essential Castell2005Devlin2006.
Stability and Administration Considerations
The stability of omeprazole in IR formulations depends on maintaining a sufficiently high pH during dissolution. Formulations with pure omeprazole and sodium bicarbonate show the best stability and drug recovery, with up to 74% released at pH 6 . IR omeprazole powder for oral suspension is suitable for administration via nasogastric or orogastric tubes, with minimal risk of tube obstruction due to the small particle size and absence of enteric coating . This makes it a practical option for critically ill or dysphagic patients .
Comparative Efficacy
Studies show that IR omeprazole formulations with sodium bicarbonate are as effective as DR omeprazole in reducing gastric acidity at steady state . The rapid onset and flexible dosing provide additional clinical advantages, especially for patients with variable dosing needs or those at risk for stress-related mucosal bleeding Peura2005Castell2005Kim2018.
Conclusion
Immediate-release omeprazole formulations, primarily using sodium bicarbonate as a buffering agent, offer rapid absorption, quick onset of action, and effective acid suppression. These features make them suitable for on-demand therapy, nocturnal acid control, and use in critically ill patients, addressing several unmet needs associated with traditional delayed-release PPIs Peura2005Castell2005Ramesh2025+1 MORE.
Sources and full results
Most relevant research papers on this topic
Preparation of Omeprazole Gastric Immediate Release Tablets and Study on the Formulation Thereof
The optimized formulation of omeprazole gastric immediate release tablets with microcapsules and antacid agents effectively reduces oral omeprazole degradation and improves dissolution in gastric acid medium.
Acid-Neutralizing Omeprazole Formulation for Rapid Release and Absorption
A sodium bicarbonate-based omeprazole formulation with sodium bicarbonate effectively neutralizes stomach acid, facilitating rapid release and absorption, making it an easily manufacturable alternative to enteric-coated omeprazole.
Bioequivalence Study of Two Oral-Capsule Formulations of Omeprazole 20 mg in Combination with Sodium Bicarbonate in Healthy Mexican Adult Volunteers
The immediate-release formulation of omeprazole 20 mg in combination with sodium bicarbonate is bioequivalent to the delayed-release formulation in treating gastritis, reflux, heartburn, and emptiness caused by excessive acid production in healthy Mexican adult volunteers.
DOI